<PAGE>
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-QSB/A
(MARK ONE)
/X/ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the period ended June 30, 1996
OR
/ / TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from to .
Commission File Number 000-21141
-----------
PHARNAPRINT INC. (FORMERLY ABT GLOBAL PHARMACEUTICAL CORP.)
--------------------------------------------------------------
(Exact name of registrant as specified in its charter)
California 33-0640125
- --------------------------------------------------------------------------------
(State or jurisdiction of incorporation or (I.R.S. Employer Identification No.)
organization)
5 Park Place, Suite 770, Irvine, California 92614
--------------------------------------------------------------
(Address of principal executive officers) (Zip Code)
Registrant's telephone number, including area code: (714) 224-2555
--------------
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes / / No /X/ - Registrant has not been subject to such filing
requirements for the past 90 days.
There were 11,000,000 issued and outstanding shares of the registrant's common
stock, without par value, at September 24, 1996.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
pHARMAPRINT INC. (FORMERLY
ABT GLOBAL PHARMACEUTICAL CORP.)
Registrant
Date: November 5, 1996 /s/ Elliot P. Friedman
-------------------------------------
Elliot P. Friedman
President, Chief Executive Officer,
Chief Financial Officer and Director
<PAGE>
Exhibit Index
Exhibit
Number
- -------
27 Financial Data Schedule
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-1996
<PERIOD-START> APR-01-1996
<PERIOD-END> JUN-30-1996
<CASH> 275,708
<SECURITIES> 0
<RECEIVABLES> 12,903
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 587,289
<PP&E> 4,799
<DEPRECIATION> (240)
<TOTAL-ASSETS> 642,353
<CURRENT-LIABILITIES> (622,719)
<BONDS> 0
0
0
<COMMON> (7,349,947)
<OTHER-SE> 7,330,313
<TOTAL-LIABILITY-AND-EQUITY> (642,353)
<SALES> 0
<TOTAL-REVENUES> 0
<CGS> 0
<TOTAL-COSTS> 2,401,459
<OTHER-EXPENSES> 89,061
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 15,625
<INCOME-PRETAX> (2,490,520)
<INCOME-TAX> 0
<INCOME-CONTINUING> (2,401,459)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (2,490,520)
<EPS-PRIMARY> (.30)
<EPS-DILUTED> (.30)
</TABLE>
